Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
This finding, which is in keeping with initial studies out of China and Italy, is preliminary as the CDC continues to gather data.
Women with a history of the malignancy also survive longer than men after receiving a liver transplant.
An analysis conducted in Taiwan analyzed health outcomes over more than a decade.
Researchers compared direct-acting-antiviral treatment outcomes between those with and without a history of liver cancer.
Researchers analyzed a cohort of South Koreans taking Viread (tenofovir disoproxil fumarate) or Baraclude (entecavir) for hepatitis B.
These rates are driven in large part by hepatitis B and C.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.